开云体育
T. R. Wassenaar
All authors
About
Publications While At 开云体育
selected publications
Journal Article
Validation of immunotherapy response score as predictive of pan-solid tumor anti-PD-1/PD-L1 benefit
.
Cancer Res Commun.
2023
Randomized phase II trial of fulvestrant plus everolimus or placebo in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer resistant to aromatase inhibitor therapy: results of PrE0102
.
Journal of Clinical Oncology.
2018
Contact
full name
T. R.
Wassenaar
Quick Info
Publications
Publications in the past 10 years based solely on publications while at 开云体育. Publications in prior years appear in grey.
Collaboration
Co-author network
Map of science